Is Your AI Tool Clinically Ready?
Bobbi Pritt on validation evidence, bias, interoperability, and why workflow integration matters most
By
Jessica Allerton
February 9, 2026
Clinical Scorecard: Is Your AI Tool Clinically Ready?
At a Glance
Category Detail
Condition Clinical Pathology and Microbiology Key Mechanisms AI assists in image analysis, quality control, triage, and workflow automation. Target Population Pathologists and clinical microbiologists. Care Setting Laboratories and clinical pathology departments.
Key Highlights
AI enhances efficiency by reducing slide review time from 5 minutes to 30 seconds. AI is effective in screening negative slides, which constitute 90-95% of specimens. Integration of AI tools into existing laboratory workflows is crucial for clinical adoption. Pathologists must define clinical problems to guide AI development. AI can assist in interpreting complex datasets in microbiology. Guideline-Based Recommendations
Diagnosis
Evaluate AI tools based on their ability to solve specific clinical problems. Ensure AI tools are validated on independent datasets. Management
Involve pathologists in the development and validation of AI tools. Focus on explainability and interpretability of AI outputs. Monitoring & Follow-up
Assess AI performance across various real-world conditions. Monitor integration with laboratory information systems. Risks
Consider potential biases and safety issues in AI applications. Engage in discussions about reimbursement and policy implications. Patient & Prescribing Data
Patients undergoing diagnostic testing in pathology and microbiology.
AI tools can enhance diagnostic accuracy and efficiency, particularly in high-volume settings.
Clinical Best Practices
Pathologists should lead problem definition for AI tool development. Integrate AI training into pathology education for future professionals. Advocate for sustainable AI adoption through policy engagement. References
